Evidence map›Paper›PMID 38535575›Full record

ArticlePathogens (Basel, Switzerland)2024

Inflammatory CD11b

Kazuki Nagai, Wataru Fujii, Junya Yamagishi, Chizu Sanjoba, Yasuyuki Goto

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Pro-Resolving Macrophage-Induced IL-35International journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kazuki NagaiLaboratory of Molecular Immunology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan.
Wataru FujiiLaboratory of Biomedical Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan.
Junya YamagishiInternational Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan.ORCID 0000-0002-8385-5359
Chizu SanjobaLaboratory of Molecular Immunology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan.ORCID 0000-0002-4581-4038
Yasuyuki GotoLaboratory of Molecular Immunology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan.ORCID 0000-0002-8654-7888
The University of Tokyo · JPHokkaido University · JP

Funding

Hokkaido University International Institute for Zoonosis Control 2021, 2022, 2023Japan Society for the Promotion of Science 21H02722, 22H05057
6 · The paper itself

Abstract

Visceral leishmaniasis (VL) is an infectious disease caused by parasitic protozoa of the genus

Indexed as

B-Cell Activating FactorCD11b AntigenLeishmania donovaniLeishmaniasis, VisceralMacrophagesSpleenAnimalsFemaleMiceMice, Inbred BALB CSplenomegalyB-Cell Activating FactorCD11b AntigenItgam protein, mouseTnfsf13b protein, mouseB-cell-activating factor (BAFF)CD11bLeishmania donovanimacrophagespleenvisceral leishmaniasis

Identifiers

PMID38535575
PMCPMC10975664
OpenAlexW4392553537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.